Ted White
President and CEO at Verrica Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Verrica Pharmaceuticals Inc., 3 years.
Verrica Pharmaceuticals Inc.
Director · PRESIDENT AND CEO
Chief executive roles
Verrica Pharmaceuticals Inc.
· President and CEO
Until November 2024
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 27, 2024 | Verrica Pharmaceuticals Inc. | Open-market sale | −9,021 | $2.46 | $22,192 |
| Aug 26, 2024 | Verrica Pharmaceuticals Inc. | Open-market sale | −24,979 | $2.66 | $66,444 |
| Jul 23, 2024 | Verrica Pharmaceuticals Inc. | Open-market sale | −154 | $6.98 | $1,075 |
| Jul 22, 2024 | Verrica Pharmaceuticals Inc. | Open-market sale | −32,469 | $7.06 | $229,231 |
| Mar 15, 2024 | Verrica Pharmaceuticals Inc. | Grant or award | +112,500 | — | — |
| Nov 15, 2023 | Verrica Pharmaceuticals Inc. | Open-market sale | −11,558 | $2.97 | $34,327 |
| Nov 14, 2023 | Verrica Pharmaceuticals Inc. | Open-market sale | −22,141 | $2.93 | $64,873 |
| Aug 24, 2023 | Verrica Pharmaceuticals Inc. | Grant or award | +75,000 | — | — |
| Jul 24, 2023 | Verrica Pharmaceuticals Inc. | Open-market sale | −50,677 | $4.83 | $244,770 |
| Jul 21, 2023 | Verrica Pharmaceuticals Inc. | Grant or award | +150,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.